Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
G Daniel Brooks. (2020) Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes. Therapeutics and Clinical Risk Management 16, pages 181-187.
Read now
Read now
Shoroq M. Altawalbeh, Nour A. Manoon, Mera A. Ababneh & Iman A. Basheti. (2020) Respiratory tract infection-induced asthma exacerbations in adults with asthma: assessing predictors and outcomes. Journal of Asthma 57:3, pages 231-240.
Read now
Read now
Giancarlo Marone, Giuseppe Spadaro, Mariantonia Braile, Remo Poto, Gjada Criscuolo, Hadas Pahima, Stefania Loffredo, Francesca Levi-Schaffer & Gilda Varricchi. (2019) Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma. Expert Opinion on Investigational Drugs 28:11, pages 931-940.
Read now
Read now
Yazan Zayed, Babikir Kheiri, Momen Banifadel, Michael Hicks, Ahmed Aburahma, Kewan Hamid, Ghassan Bachuwa & Arul Chandran. (2019) Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials. Journal of Asthma 56:10, pages 1110-1119.
Read now
Read now
Stephanie Chen, Sarowar Golam, Julie Myers, Chris Bly, Harry Smolen & Xiao Xu. (2018) Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion 34:12, pages 2075-2088.
Read now
Read now
Leo Nygaard, Daniel Pilsgaard Henriksen, Hanne Madsen & Jesper Rømhild Davidsen. (2017) Appropriate selection for omalizumab treatment in patients with severe asthma?. European Clinical Respiratory Journal 4:1.
Read now
Read now
Jeanine A Driesenaar, Peter AGM De Smet, Rolf van Hulten, Litje Hu & Sandra van Dulmen. (2016) Communication during counseling sessions about inhaled corticosteroids at the community pharmacy. Patient Preference and Adherence 10, pages 2239-2254.
Read now
Read now
Tatiana Zacarias Rondinel, Isadora Faraco Corrêa, Luíza Machado Hoscheidt, Mirelle Hugo Bueno, Luciano Muller Corrêa da Silva, Caroline Tozzi Reppold & Pedro Dal Lago. (2015) Incentive spirometry combined with expiratory positive airway pressure improves asthma control and quality of life in asthma: a randomised controlled trial. Journal of Asthma 52:2, pages 220-226.
Read now
Read now
MNA Van Steenis, JA Driesenaar, JM Bensing, R Van Hulten, PC Souverein, L Van Dijk, PAGM De Smet & AM Van Dulmen. (2014) Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Preference and Adherence 8, pages 83-91.
Read now
Read now
A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, R. Stanford, Z. Su & J. S. Sampalis. (2014) Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Current Medical Research and Opinion 30:7, pages 1417-1425.
Read now
Read now
Mustafa Arga, Hasibe Sahbaz, Arzu Bakirtas, Ipek Turktas & M. Sadik Demirsoy. (2014) Does self-monitoring by means of symptom diaries improve asthma control in children?. Journal of Asthma 51:3, pages 299-305.
Read now
Read now
Anthony C. A. Yii & Mariko S. Koh. (2013) A review of psychological dysfunction in asthma: affective, behavioral and cognitive factors. Journal of Asthma 50:9, pages 915-921.
Read now
Read now
Katsuyuki Tomita, Hiroyuki Sano, Takashi Iwanaga, Kyosuke Ishihara, Masakazu Ichinose, Ichirou Kawase, Hiroshi Kimura, Kazuto Hirata, Masaki Fujimura, Michiaki Mishima & Yuji Tohda. (2012) Association between Episodes of Upper Respiratory Infection and Exacerbations in Adult Patients with Asthma. Journal of Asthma 49:3, pages 253-259.
Read now
Read now
Claire Fuhrman, Jean-Christophe Dubus, Christophe Marguet, Christophe Delacourt, Caroline Thumerelle, Jacques de Blic & Marie-Christine Delmas. (2011) Hospitalizations for Asthma in Children Are Linked to Undertreatment and Insufficient Asthma Education. Journal of Asthma 48:6, pages 565-571.
Read now
Read now
Articles from other publishers (38)
Yu Zhao Lee, Audrey Siew Foong Kow, Alain Jacquet, Ming Tatt Lee & Chau Ling Tham. (2023) House dust mite allergy in Malaysia: review of research gaps in the current scenario and the way forward. Experimental and Applied Acarology 91:4, pages 509-539.
Crossref
Crossref
Maho Suzukawa, Ken Ohta, Yuma Fukutomi, Hiroya Hashimoto, Takeo Endo, Masahiro Abe, Yosuke Kamide, Makoto Yoshida, Yoshihiro Kikuchi, Toshiyuki Kita, Kenji Chibana, Yasushi Tanimoto, Kentaro Hyodo, Shohei Takata, Toshiya Inui, Masahide Yasui, Yoshinori Harada, Toshio Sato, Yumi Sakakibara, Yoshiaki Minakata, Yoshikazu Inoue, Shinji Tamaki, Tsutomu Shinohara, Kazutaka Takami, Motofumi Tsubakihara, Masahide Oki, Kentaro Wakamatsu, Masahide Horiba, Gen Ideura, Koko Hidaka, Akiko M. Saito, Nobuyuki Kobayashi & Masami Taniguchi. (2023) Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study). Allergology International 72:1, pages 63-74.
Crossref
Crossref
Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira L. Lugogo, Philip Bardin, Martti Antila, David M.G. Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob-Nara, Rebecca Gall, Yamo Deniz & Paul J. Rowe. (2022) Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. Respiratory Medicine 202, pages 106938.
Crossref
Crossref
Naoki Kotani, Michael Dolton, Robin J. Svensson, Jakob Ribbing, Lena E. Friberg, Shweta Vadhavkar, Dorothy Cheung, Tracy Staton, Gizette Sperinde, Jin Jin, Wendy S. Putnam & Angelica Quartino. (2022) Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma. The Journal of Clinical Pharmacology 62:7, pages 905-917.
Crossref
Crossref
Alexandrosz Czira, Monica Turner, Amber Martin, David Hinds, Helen Birch, Frances Gardiner & Shiyuan Zhang. (2022) A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma. Respiratory Medicine 191, pages 106670.
Crossref
Crossref
Annamaria BOSI, Roberto TONELLI, Ivana CASTANIERE, Enrico CLINI & Bianca BEGHÈ. (2021) Acute severe asthma: management and treatment. Minerva Medica 112:5.
Crossref
Crossref
Robin J Svensson, Jakob Ribbing, Naoki Kotani, Michael Dolton, Shweta Vadhavkar, Dorothy Cheung, Tracy Staton, David F Choy, Wendy Putnam, Jin Jin, Nageshwar Budha, Mats O. Karlsson, Angelica Quartino & Rui Zhu. (2021) Population repeated time‐to‐event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires. CPT: Pharmacometrics & Systems Pharmacology 10:10, pages 1221-1235.
Crossref
Crossref
Li Zhang, Yue Gao, Meng Li, Christine Xu, John D. Davis, Vanaja Kanamaluru & Qiang Lu. (2021) Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthma. CPT: Pharmacometrics & Systems Pharmacology 10:8, pages 941-952.
Crossref
Crossref
Arnaud Bourdin, Alberto A. Papi, Jonathan Corren, J. Christian Virchow, Megan S. Rice, Yamo Deniz, Michel Djandji, Paul Rowe & Ian D. Pavord. (2020) Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline. Allergy 76:1, pages 269-280.
Crossref
Crossref
Paz Vaquero-Lozano, Inmaculada Lassaletta-Goñi, Jordi Giner-Donaire, María del Carmen Gómez-Neira, Joan Serra-Batlles, Rocío García-García, Francisco Javier Álvarez-Gutiérrez, Marina Blanco-Aparicio & David Díaz-Pérez. (2021) Documento de consenso de enfermería en asma 2020. Open Respiratory Archives 3:1, pages 100079.
Crossref
Crossref
Michael E. Wechsler, Lisa Hickey, Margaret Garin & Anoop Chauhan. (2020) Efficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:10, pages 3434-3442.e4.
Crossref
Crossref
Laura Amanda Vallejo-Aparicio, Jesús Molina, Iñigo Ojanguren, Ana Viejo Casas, Alicia Huerta & Henrik Svedsater. (2019) Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma. The European Journal of Health Economics 21:1, pages 7-17.
Crossref
Crossref
Koichi Ando, Akihiko Tanaka & Hironori Sagara. (2020) Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review. International Journal of Molecular Sciences 21:3, pages 889.
Crossref
Crossref
Mario Castro, Klaus F. Rabe, Jonathan Corren, Ian D. Pavord, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Megan S. Rice, Jaman Maroni, Paul Rowe, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham & Ariel Teper. (2020) Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. ERJ Open Research 6:1, pages 00204-2019.
Crossref
Crossref
Wei Liu, Wei Mu, Huiting Zhang, Jingbo Zhai, Xiaodan Li, Peng Guan, Fu Lian, Jihong Feng, Shuangjiang Yu, Xuepin Wang, Jinhua Si, Zengtao Sun & Yuhong Huang. (2020) Azithromycin as an add-on treatment for persistent uncontrolled asthma in adults: protocol of a systematic review and meta-analysis. BMJ Open 10:1, pages e032770.
Crossref
Crossref
Hiroyuki Nagase, Mitsuru Adachi, Kazuto Matsunaga, Atsushi Yoshida, Tomoko Okoba, Nobuya Hayashi, Kahaku Emoto & Yuji Tohda. (2020) Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergology International 69:1, pages 53-60.
Crossref
Crossref
James G. Krings, Mary Clare McGregor, Leonard B. Bacharier & Mario Castro. (2019) Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1379-1392.
Crossref
Crossref
Woo-Jung Song, Ji-Hyang Lee, Yewon Kang, Woo Joung Joung & Kian Fan Chung. (2019) Future Risks in Patients With Severe Asthma. Allergy, Asthma & Immunology Research 11:6, pages 763.
Crossref
Crossref
Sarah Stutfield. (2018) Raising the Clinical Bar Beyond Current Biologics in Uncontrolled Persistent Asthma: Translating Emerging Data in Future Clinical Decisions. EMJ Allergy & Immunology, pages 60-69.
Crossref
Crossref
M. T. Kasaian, J. Lee, A. Brennan, S. I. Danto, K. E. Black, L. Fitz & A. E. Dixon. (2018) Proteomic analysis of serum and sputum analytes distinguishes controlled and poorly controlled asthmatics. Clinical & Experimental Allergy 48:7, pages 814-824.
Crossref
Crossref
Mario CastroJonathan CorrenIan D. PavordJorge MasperoSally WenzelKlaus F. RabeWilliam W. BusseLinda FordLawrence SherJ. Mark FitzGeraldConstance KatelarisYuji TohdaBingzhi ZhangHeribert StaudingerGianluca PirozziNikhil AminMarcella RuddyBolanle AkinladeAsif KhanJingdong ChaoRenata MartincovaNeil M.H. GrahamJennifer D. HamiltonBrian N. SwansonNeil StahlGeorge D. YancopoulosAriel Teper. (2018) Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. New England Journal of Medicine 378:26, pages 2486-2496.
Crossref
Crossref
Jae-Uk Song, Hye Kyeong Park & Jonghoo Lee. (2018) Impact of dosage timing of once-daily inhaled corticosteroids in asthma. Annals of Allergy, Asthma & Immunology 120:5, pages 512-519.
Crossref
Crossref
Louise Zierau, Emil Schwarz Walsted, Simon Francis Thomsen & Vibeke Backer. (2017) Response to omalizumab in patients with severe allergic asthma: A real-life study. Respiratory Medicine 131, pages 109-113.
Crossref
Crossref
María del Carmen Vennera, Antonio Valero, Estefany Uría, Carles Forné & César Picado. (2016) Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain. Clinical Drug Investigation 36:7, pages 567-578.
Crossref
Crossref
Vanessa E Craven, Robert W Morton, Sally Spencer, Sunalene G Devadason & Mark L Everard. (2015) Electronic monitoring and reminding devices for improving adherence to inhaled therapy in patients with asthma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David Price, Brooke Harrow, Mark Small, James Pike & Victoria Higgins. (2015) Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organization Journal 8, pages 26.
Crossref
Crossref
Jan Lötvall, Eugene R. Bleecker, William W. Busse, Paul M. O'Byrne, Ashley Woodcock, Edward M. Kerwin, Sally Stone, Richard Forth, Loretta Jacques & Eric D. Bateman. (2014) Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial. Respiratory Medicine 108:1, pages 41-49.
Crossref
Crossref
Malin Axelsson. (2013) Personality and reasons for not using asthma medication in young adults. Heart & Lung 42:4, pages 241-246.
Crossref
Crossref
Jennifer E. Zora, Stefanie Ebelt Sarnat, Amit U. Raysoni, Brent A. Johnson, Wen-Whai Li, Roby Greenwald, Fernando Holguin, Thomas H. Stock & Jeremy A. Sarnat. (2013) Associations between urban air pollution and pediatric asthma control in El Paso, Texas. Science of The Total Environment 448, pages 56-65.
Crossref
Crossref
Richard Sterling, Jessica Lim, Lucy Frith, Neil G. Snowise, Loretta Jacques & Brett Haumann. (2012) Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial. Respiratory Medicine 106:8, pages 1110-1115.
Crossref
Crossref
Hilary Medley, Socorro Orozco & Ann Allen. (2012) Efficacy and Safety Profile of Fluticasone Furoate Administered Once Daily in the Morning or Evening: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial in Adult and Adolescent Patients With Persistent Bronchial Asthma. Clinical Therapeutics 34:8, pages 1683-1695.
Crossref
Crossref
Paula Cristina Andrade Almeida, Adelmir Souza-Machado, Mylene dos Santos Leite, Lourdes Alzimar Mendes de Castro, Ana Carla Carvalho Coelho, Constança Sampaio Cruz & Álvaro Augusto Cruz. (2012) Comparação entre dois métodos de avaliação do controle da asma baseados na percepção individual. Jornal Brasileiro de Pneumologia 38:3, pages 299-307.
Crossref
Crossref
Tanja T. Menckeberg, Jacqueline G. Hugtenburg, Jan Willem Lammers, Jan A. M. Raaijmakers & Marcel L. Bouvy. (2012) Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early. International Journal of Clinical Pharmacy 34:2, pages 277-281.
Crossref
Crossref
Ashley Woodcock, Eric D Bateman, William W Busse, Jan Lötvall, Neil G Snowise, Richard Forth, Loretta Jacques, Brett Haumann & Eugene R Bleecker. (2011) Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. Respiratory Research 12:1.
Crossref
Crossref
A. Carsin & N. Pham-Thi. (2011) Exacerbations asthmatiques : spécificités pédiatriques (en dehors du traitement). Revue des Maladies Respiratoires 28:10, pages 1322-1328.
Crossref
Crossref
Bandana Saini, Kate LeMay, Lynne Emmerton, Ines Krass, Lorraine Smith, Sinthia Bosnic-Anticevich, Kay Stewart, Deborah Burton & Carol Armour. (2011) Asthma disease management—Australian pharmacists’ interventions improve patients’ asthma knowledge and this is sustained. Patient Education and Counseling 83:3, pages 295-302.
Crossref
Crossref
Inseon S Choi. (2011) Gender-Specific Asthma Treatment. Allergy, Asthma and Immunology Research 3:2, pages 74.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Pulmonary Medicine 17:1, pages 50-53.
Crossref
Crossref